IDH1/2Mutations Sensitize Acute Myeloid Leukemia to PARP Inhibition and This Is Reversed by IDH1/2-Mutant Inhibitors

Title
IDH1/2Mutations Sensitize Acute Myeloid Leukemia to PARP Inhibition and This Is Reversed by IDH1/2-Mutant Inhibitors
Authors
Keywords
-
Journal
CLINICAL CANCER RESEARCH
Volume 24, Issue 7, Pages 1705-1715
Publisher
American Association for Cancer Research (AACR)
Online
2018-01-17
DOI
10.1158/1078-0432.ccr-17-2796

Ask authors/readers for more resources

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started